Repair of the calvarial defect in goat model using magnesium-doped porous hydroxyapatite combined with recombinant human bone morphogenetic protein-2
Source abstract
Abstract
Hydroxyapatite (HA) is a representative bone repairing biomaterial for its similar composition to human bones and teeth. However, pure HA is limited in application for some unwanted characteristic, such as it is brickle and weakness in degradation. In this study, we modified HA by doping magnesium (Mg) to the material and studied its property in vitro. Besides, we also evaluated the calvarial defect repair effect using MgHA combined with rhBMP-2 in goat model. According to our outcomes, HA composited Mg made the scaffold smooth and the pore regular. In vitro study, Mg could increase the Ca releasing, which may reflect a faster degradation property modified by Mg. And then, MgHA improved the cell viability and proliferation. Furthermore, MgHA could increase the expression of ALP, Collagen I and VEGF protein compared with pure HA (p<0.5, respectively). In the vivo study, MgHA showed a better bone defect healing effect in computed tomography (CT) evaluation compared with HA (p<0.05), but it was inferior to the MgHA/rhBMP-2 (p<0.05). Besides, in the histological analysis, MgHA/rhBMP-2 showed the most effective bone formation outcome (p<0.05), and the MgHA group was significant better than the pure HA group on osteogenesis (p<0.05). Furthermore, Collagen I and VEGF mRNA expression at 12 week in MgHA/rhBMP-2 group were also significat higher than other two groups. In conclusion, Mg had effects on bone formation and angiogenesis, and MgHA/rhBMP-2 had improved the bone defect repair effect. It is worthy of being recommended to bone tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedics surgery, West China Hospital, Sichuan University, 37# Wainan Guoxue Road, Chengdu 610041, People’s Republic of China. E-mails: 604982346@qq.com, LiDh9090@163.com, yangzhouyuan1986@163.com, 459519596@qq.com, kangpd@163.com
Department of Orthopaedics surgery, Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region, 20# Ximianqiaoheng street, Chengdu 610041, People’s Republic of China
References (39)
Show source-provided references
1. 10.1186/s40902-015-0015-310.1186/s40902-015-0015-3 ↗
2. A comparison of the healing capabilities of various grafting materials in critical-size defects in guinea pig calvaria10.11607/jomi.2906 ↗
3. Antigen-free bovine cancellous bone loaded with recombinant human bone morphogenetic protein-2 for the repair of tibial bone defects in goat model10.1177/0885328215627796 ↗
4. 10.1007/s10856-016-5714-510.1007/s10856-016-5714-5 ↗
5. Various preparation methods of highly porous hydroxyapatite/polymer nanoscale biocomposites for bone regeneration10.1016/j.actbio.2011.07.002 ↗
6. 10.1177/088532821665727110.1177/0885328216657271 ↗
7. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel10.1021/cr8004422 ↗
8. Effect of dissolution/precipitation on the residual stress redistribution of plasma-sprayed hydroxyapatite coating on titanium substrate in simulated body fluid (SBF)10.1016/j.jmbbm.2014.04.007 ↗
9. Bone tissue engineering therapeutics: Controlled drug delivery in three-dimensional scaffolds10.1098/rsif.2009.0379 ↗
10. Long lasting outcome of hydroxyapatite-coated implants in primary knee arthroplasty: A continuous series of two hundred and seventy total knee arthroplasties at fifteen to twenty two years of clinical follow-up10.1007/s00264-013-2246-1 ↗
11. Clinical and radiologic outcomes of a fully hydroxyapatite-coated femoral revision stem: Excessive stress shielding incidence and its consequences10.1016/j.arth.2015.08.037 ↗
12. Improving the degradation behavior and in vitro biological property of nano-hydroxyapatite surface- grafted with the assist of citric acid10.1016/j.colsurfb.2016.05.062 ↗
13. Bone formation and degradation behavior of nanocrystalline hydroxyapatite with or without collagen-type 1 in osteoporotic bone defects – an experimental study in osteoporotic goats10.1016/S0020-1383(16)47010-5 ↗
14. 10.1007/s11051-014-2622-910.1007/s11051-014-2622-9 ↗
15. Controlling of dielectrical and optical properties of hydroxyapatite based bioceramics by Cd content10.1016/j.powtec.2013.04.012 ↗
16. Enhancement of osteogenesis and biodegradation control by brushite coating on Mg–Nd–Zn–Zr alloy for mandibular bone repair10.1021/am506543a ↗
17. Surface modification of strontium-doped porous bioactive ceramic scaffolds via poly(DOPA) coating and immobilizing silk fibroin for excellent angiogenic and osteogenic properties10.1039/C5BM00482A ↗
18. 10.1007/s10856-015-5479-210.1007/s10856-015-5479-2 ↗
19. In vivo corrosion of four magnesium alloys and the associated bone response10.1016/j.Biomaterials2004.09.049 ↗
20. Magnesium and its alloys as orthopedic biomaterials: A review10.1016/j.Biomaterials2005.10.003 ↗
21. In vitro and in vivo corrosion measurements of magnesium alloys10.1016/j.Biomaterials2005.07.037 ↗
22. Endothelial responses of magnesium and other alloying elements in magnesium-based stent materials10.1039/C4MT00244J ↗
23. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro10.1016/j.bbadis.2004.02.004 ↗
24. In vitro corrosion behaviour of Mg alloys in a phosphate buffered solution for bone implant application10.1007/s10856-007-3219-y ↗
25. The development of binary Mg–Ca alloys for use as biodegradable materials within bone10.1016/j.Biomaterials2007.12.021 ↗
26. In vitro evaluation of rhBMP-2 induced expression of VEGF in human adipose-derived stromal cells
27. A novel strontium(II)-modified calcium phosphate bone cement stimulates human-bone-marrow-derived mesenchymal stem cell proliferation and osteogenic differentiation in vitro10.1016/j.actbio.2013.07.027 ↗
28. Magnesium modification of a calcium phosphate cement alters bone marrow stromal cell behavior via an integrin-mediated mechanism10.1016/j.Biomaterials2015.02.097 ↗
29. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration10.1016/j.Biomaterials2008.03.036 ↗
30. Effect of chemistry on osteogenesis and angiogenesis towards bone tissue engineering using 3D printed scaffolds10.1007/s10439-016-1646-y ↗
31. 10.1088/1748-6041/3/4/04410510.1088/1748-6041/3/4/044105 ↗
32. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat10.1016/j.bone.2005.04.005 ↗
33. Hierarchically microporous/macroporous scaffold of magnesium-calcium phosphate for bone tissue regeneration10.1016/j.Biomaterials2009.11.005 ↗
34. Self-setting bioactive calcium-magnesium phosphate cement with high strength and degradability for bone regeneration10.1016/j.actbio.2008.06.020 ↗
35. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro10.1016/j.bbadis.2004.02.004 ↗
36. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration10.1161/01.RES.67.3.645 ↗
37. Enhanced angiogenesis of porous collagen scaolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor10.1016/j.actbio.2009.04.004 ↗
38. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization10.1016/j.Biomaterials2008.09.047 ↗
39. Repair of rat calvarial defects using Si-doped hydroxyapatite scaffolds loaded with a bone morphogenetic protein-2-related peptide10.1002/jor.23208 ↗